Therefore, future studies should analyze the possible interaction between CYP2D6 gene variants and the variants of the SLC6A3, HTR2C and HTR6 genes on the risk for haloperidol-induced parkinsonism. The gene discussed is SLC6A3; the disease is Parkinson disease.